TR201007652A2 - Synergistic effect. - Google Patents
Synergistic effect.Info
- Publication number
- TR201007652A2 TR201007652A2 TR2010/07652A TR201007652A TR201007652A2 TR 201007652 A2 TR201007652 A2 TR 201007652A2 TR 2010/07652 A TR2010/07652 A TR 2010/07652A TR 201007652 A TR201007652 A TR 201007652A TR 201007652 A2 TR201007652 A2 TR 201007652A2
- Authority
- TR
- Turkey
- Prior art keywords
- synergistic effect
- acetylcysteine
- sedative
- generation
- invention includes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş; bir mukolitik ajan olan N-Asetilsistein ile üçüncü kuşak ve sedatif olmayan Hl reseptör antagonistinin kombine halde kullanılması ve bu kombinasyonu içeren solunum yolu hastalıklarında kullanılabilen ilaç bileşimleri ile ilgilidir.The present invention includes; and N-Acetylcysteine, a mucolytic agent, and a third generation and non-sedative H1 receptor antagonist.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/07652A TR201007652A2 (en) | 2010-09-20 | 2010-09-20 | Synergistic effect. |
PCT/TR2011/000213 WO2012039691A2 (en) | 2010-09-20 | 2011-09-20 | Synergic effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/07652A TR201007652A2 (en) | 2010-09-20 | 2010-09-20 | Synergistic effect. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201007652A2 true TR201007652A2 (en) | 2012-04-24 |
Family
ID=45034153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2010/07652A TR201007652A2 (en) | 2010-09-20 | 2010-09-20 | Synergistic effect. |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR201007652A2 (en) |
WO (1) | WO2012039691A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106109422A (en) * | 2016-07-28 | 2016-11-16 | 北京万全德众医药生物技术有限公司 | Levo-cetirizine hydrochloride effervescent granule and preparation method thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3184505A (en) | 1962-06-18 | 1965-05-18 | Mead Johnson & Co | Process for the n-monoacylation of cysteine |
NO155805C (en) | 1981-02-06 | 1987-06-10 | Ucb Sa | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 2- (4- (DIPHENYLMETHYL) -1-PIPERAZINYL) -ACDIC ACIDS AND THEIR AMIDS AND NON-TOXIC SALTS. |
JPS61501205A (en) | 1984-02-15 | 1986-06-19 | シェリング・コ−ポレ−ション | 8↓-chloro↓-6,11↓-dihydro↓-11↓-(4↓-piperidylidene)↓-5H↓-benzo[5,6]cyclohepta[1,2-b]pyridine and its salts, compounds thereof and pharmaceutical compositions containing these compounds. |
GB8827391D0 (en) | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride |
DE69320975T2 (en) | 1992-09-24 | 1999-05-12 | Sepracor Inc | Use of (-) cetirizine for the treatment of allergic rhinitis and and asthma |
WO2001085148A2 (en) * | 2000-05-05 | 2001-11-15 | Aventis Pharmaceuticals Inc. | Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride |
EP1696881A2 (en) * | 2003-12-23 | 2006-09-06 | Sun Pharmaceutical Industries Limited | Stable oral composition |
US20080139654A1 (en) * | 2006-12-09 | 2008-06-12 | Eric Mott Soderling | Acetaminophen compositions having minimized side effects including reduced hepatotoxicity |
-
2010
- 2010-09-20 TR TR2010/07652A patent/TR201007652A2/en unknown
-
2011
- 2011-09-20 WO PCT/TR2011/000213 patent/WO2012039691A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012039691A3 (en) | 2012-05-18 |
WO2012039691A2 (en) | 2012-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121390T1 (en) | PYRROLOVENZODIAZEPINE AND CONCOMES OF THEM | |
TR201910662T4 (en) | Pyrrolobenzodiazepines and their conjugates. | |
CL2012002979A1 (en) | N3-substituted-n1-sulfonyl-5-fluorpyrimidinone derivatives. | |
GB2506783A (en) | Enabling a computing device to utilize another computing device | |
TR201903569T4 (en) | A delayed release drug formulation. | |
TR201907828T4 (en) | AN ANTI-MICROBIAL AGENT WITH A WIDE SPECTRUM | |
BR112015019647A2 (en) | path profiling using combination of hardware and software. | |
UY4223Q (en) | BANK | |
IT1403120B1 (en) | WELDING MACHINE WITH ACOUSTIC MESSAGES. | |
TR201904120T4 (en) | Connector part. | |
CL2009001973S1 (en) | Counter. | |
FR2964411B1 (en) | DUST OF TURBOREACTOR, IN PARTICULAR A DRAWER OF RECTIFIER, AND TURBOJET RECEIVING SUCH AS AUBES | |
Naimisharay | Apne Apne Pinjare-2 | |
TR200903176A1 (en) | Multiple blister. | |
TR201007652A2 (en) | Synergistic effect. | |
UY4243Q (en) | BANK | |
IT1399443B1 (en) | UNDERGARMENT. | |
IT1399581B1 (en) | DEVICE FOR THE PROTECTION OF PARTS OF THE BODY OF AN INDIVIDUAL, IN PARTICULAR FOR THE BACK PROTECTION. | |
TR201900608T4 (en) | Hood device with an air preparation device. | |
TR201005220U (en) | Innovation in reels used for shipping cables. | |
TN2010000567A1 (en) | المحطة الكهرمائية الشمسية | |
TN2010000017A1 (en) | مستحضر تجميلي دوائي | |
TR201107297U (en) | A hairbrush. | |
UA71429U (en) | Hepatoprotector | |
ES1074160Y (en) | BACK TRAY WITH DOUBLE OPENING FOR CAR. |